Brooklyn Immunotherapeutics (BTX) CEO On Stock's +320% Rally In 2021

Brooklyn Therapeutics CEO Howard Federoff joins the Watch List to discuss future growth prospects for the company amid the rapidly evolving biopharmaceutical environment. Brooklyn Therapeutics is focused on Cytokine-based therapies in treating patients with cancer, and is also engaged in developing IRX-2.

The Watch List

24 Jun 2021

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US

Brooklyn Immunotherapeutics (BTX) CEO On Stock's +320% Rally In 2021

Brooklyn Therapeutics CEO Howard Federoff joins the Watch List to discuss future growth prospects for the company amid the rapidly evolving biopharmaceutical environment. Brooklyn Therapeutics is focused on Cytokine-based therapies in treating patients with cancer, and is also engaged in developing IRX-2.

The Watch List

24 Jun 2021

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US